 |
Frederic Waldman, MD, PhD
Recent Publications |
| |
Publications – 2007 |
 |
Adduci, K.M., C.E. Annis, S. DeVries, K.L.
Chew, J. Boutin, G. Magrane, B.M. Ljung, F.M. Waldman, and
L.J. Esserman, Fluorescence in situ hybridization of ductal
lavage samples identifies malignant phenotypes from cytologically
normal cells in women with breast cancer. Cancer, 2007. 111(3):
p. 185-91. |
|
Korkola, J.E., E. Blaveri, S. DeVries,
D.H. Moore, 2nd, E.S. Hwang, Y.Y. Chen, A.L. Estep, K.L.
Chew, R.H. Jensen, and F.M. Waldman, Identification of a
robust gene signature that predicts breast cancer outcome
in independent data sets. BMC Cancer, 2007. 7: p. 61. |
|
Publications – 2006 |
|
Chin, K., S. DeVries, J. Fridlyand, P.T.
Spellman, R. Roydasgupta, W.L. Kuo, A. Lapuk, R.M. Neve,
Z. Qian, T. Ryder, F. Chen, H. Feiler, T. Tokuyasu, C. Kingsley,
S. Dairkee, Z. Meng, K. Chew, D. Pinkel, A. Jain, B.M. Ljung,
L. Esserman, D.G. Albertson, F.M. Waldman, and J.W. Gray,
Genomic and transcriptional aberrations linked to breast
cancer pathophysiologies. Cancer Cell, 2006. 10(6): p. 529-41. |
|
Deng, G., A. Nguyen, H. Tanaka, K. Matsuzaki,
I. Bell, K.R. Mehta, J.P. Terdiman, F.M.
Waldman, S. Kakar,
J. Gum, S. Crawley, M.H. Sleisenger, and Y.S. Kim, Regional
hypermethylation and global hypomethylation are associated
with altered chromatin conformation and histone acetylation
in colorectal cancer. Int J Cancer, 2006. 118(12): p. 2999-3005. |
|
Sauter, G., P.J. Russell, and F.
Waldman,
Molecular genetics of bladder cancer, in Bladder Cancer,
S. Lerner, S. Schoenber, and M. Sternberg, Editors. 2006,
Martin Dunitz: London, England. |
|
Fridlyand, J., A.M. Snijders, B. Ylstra,
H. Li, A. Olshen, R. Segraves, S. Dairkee, T. Tokuyasu, B.M.
Ljung, A.N. Jain, J. McLennan, J. Ziegler, K. Chin, S. Devries,
H. Feiler, J.W. Gray, F. Waldman, D. Pinkel, and D.G. Albertson,
Breast tumor copy number aberration phenotypes and genomic
instability. BMC Cancer, 2006. 6: p. 96. |
|
Goodson, W.H., D.H. Moore, and F.M. Waldman,
Ki-67 correlates with in vivo bromodeoxyuridine labeling
index in operable breast cancer. J Clin Oncol, 2006. 24(23):
p. 3809; author reply 3809. |
|
Grossman, H.B., C.M. Tangen, C. Cordon-Cardo,
R. Cote, F.M. Waldman, R.W. De Vere White, A.B. Karnad, M.
Glode, and E.D. Crawford, Evaluation of Ki67, p53 and angiogenesis
in patients enrolled in a randomized study of neoadjuvant
chemotherapy with or without cystectomy: a Southwest Oncology
Group Study. Oncol Rep, 2006. 16(4): p. 807-10. |
|
Neve, R.M., K. Chin, J. Fridlyand, J. Yeh,
F.L. Baehner, T. Fevr, L. Clark, N. Bayani, J.P. Coppe, F.
Tong, T. Speed, P.T. Spellman, S. DeVries, A. Lapuk, N.J.
Wang, W.L. Kuo, J.L. Stilwell, D. Pinkel, D.G. Albertson,
F.M. Waldman, F. McCormick, R.B. Dickson, M.D. Johnson, M.
Lippman, S. Ethier, A. Gazdar, and J.W. Gray, A collection
of breast cancer cell lines for the study of functionally
distinct cancer subtypes. Cancer Cell, 2006. 10(6): p. 515-27. |
|
Rini, B.I., E. Jaeger, V. Weinberg, N.
Sein, K. Chew, K. Fong, J. Simko, E.J. Small, and F.M. Waldman,
Clinical response to therapy targeted at vascular endothelial
growth factor in metastatic renal cell carcinoma: impact
of patient characteristics and Von Hippel-Lindau gene status.
BJU Int, 2006. 98(4): p. 756-62. |
|
Sternlicht, M.D., A.M. Dunning, D.H. Moore,
P.D. Pharoah, D.G. Ginzinger, K. Chin, J.W. Gray, F.M. Waldman,
B.A. Ponder, and Z. Werb, Prognostic value of PAI1 in invasive
breast cancer: evidence that tumor-specific factors are more
important than genetic variation in regulating PAI1 expression.
Cancer Epidemiol Biomarkers Prev, 2006. 15(11): p. 2107-14. |
|
Trautmann, K., J.P. Terdiman, A.J. French,
R. Roydasgupta, N. Sein, S. Kakar, J. Fridlyand, A.M. Snijders,
D.G. Albertson, S.N. Thibodeau, and F.M. Waldman, Chromosomal
instability in microsatellite-unstable and stable colon cancer.
Clin Cancer Res, 2006. 12(21): p. 6379-85. |
|
return
to top
|
|
|
|
|
|
